{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:43:03Z","timestamp":1793947383441,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["18498"],"award-info":[{"award-number":["18498"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013874","name":"Association pour la Recherche sur les Tumeurs de la Prostate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-0030-INRT"],"award-info":[{"award-number":["ANR-10-LABX-0030-INRT"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IDEX-0002-02"],"award-info":[{"award-number":["ANR-10-IDEX-0002-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IDEX-0002"],"award-info":[{"award-number":["ANR-10-IDEX-0002"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR 20-SFRI-0012"],"award-info":[{"award-number":["ANR 20-SFRI-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-EURE-0023"],"award-info":[{"award-number":["ANR-17-EURE-0023"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prostate cancer (PCa)-related deaths are mainly due to metastasis. The increase in de novo metastatic hormone-naive PCa (mHNPCs) highlights the urgent need for biomarkers and treatment strategies. We report in a cohort of French PCa patients that the levels of vitamin D and of prostate-specific antigen, the progression biomarker used clinically, are negatively associated. However, the impact of vitamin D receptor (VDR) signaling on prostate tumorigenesis remains unclear. Mice with PTEN inactivation in prostatic epithelial cells (PECs) at adulthood (\n                    <jats:italic>Pten<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>(i)pe\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    mice) faithfully recapitulate the human disease. We showed that inactivation of PTEN and VDR in PECs promotes tumor aggressiveness. We demonstrate that VDR loss induces oxidative stress, which in turn enhances PECs proliferation. Moreover, CXCL5 overexpression in PTEN- and VDR-deficient PECs promotes neutrophil infiltration. Importantly, our data highlight elevated circulating neutrophil levels as a biomarker of PCa dissemination and show the potency of targeting neutrophil chemotaxis to reduce liver micrometastases. Overall, this work provides major insights into how vitamin D signaling slows down tumorigenesis and opens new avenues for therapeutic and diagnostic strategies for mHNPC.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00417-5","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:37:56Z","timestamp":1775785076000},"page":"1967-1989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-391X","authenticated-orcid":false,"given":"Kateryna","family":"Len-Tayon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Gantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dariane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-2349","authenticated-orcid":false,"given":"Olivier","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4585-7971","authenticated-orcid":false,"given":"Vanessa","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-5477","authenticated-orcid":false,"given":"Daniela","family":"Rovito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8272-7394","authenticated-orcid":false,"given":"Valentine","family":"Gilbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-9015","authenticated-orcid":false,"given":"Darya","family":"Yanushko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Henri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-046X","authenticated-orcid":false,"given":"Daniel","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-6877","authenticated-orcid":false,"given":"Gilles","family":"Laverny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg5982","volume":"7","author":"MA Abu El Maaty","year":"2021","unstructured":"Abu El Maaty MA, Grelet E, Keime C, Rerra A-I, Gantzer J, Emprou C, Terzic J, Lutzing R, Bornert J-M, Laverny G et al (2021) Single-cell analyses unravel cell type-specific responses to a vitamin D analog in prostatic precancerous lesions. Sci Adv 7:eabg5982","journal-title":"Sci Adv"},{"key":"417_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo2295","volume":"8","author":"MA Abu El Maaty","year":"2022","unstructured":"Abu El Maaty MA, Terzic J, Keime C, Rovito D, Lutzing R, Yanushko D, Parisotto M, Grelet E, Namer IJ, Lindner V et al (2022) Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression. Sci Adv 8:eabo2295","journal-title":"Sci Adv"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","volume":"41","author":"JM Adrover","year":"2023","unstructured":"Adrover JM, McDowell SAC, He X-Y, Quail DF, Egeblad M (2023) NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell 41:505\u2013526","journal-title":"Cancer Cell"},{"key":"417_CR67","doi-asserted-by":"publisher","unstructured":"Anders S, Huber W (2010) Differential expression analysis for sequence count data. Nat Prec https:\/\/doi.org\/10.1038\/npre.2010.4282.1","DOI":"10.1038\/npre.2010.4282.1"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/jco.2015.33.7_suppl.222","volume":"33","author":"KA Autio","year":"2015","unstructured":"Autio KA, Wong P, Rabinowitz A, Yuan J, Slavin LM, Brennan R, DerSarkissian M, Mu Z, Scher HI, Lesokhin AM (2015) Presence of myeloid-derived suppressor cells (MDSC) in patients with metastatic castration-sensitive and castration-resistant prostate cancer. JCO 33:222","journal-title":"JCO"},{"key":"417_CR5","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-06-1039","volume":"12","author":"W Banach-Petrosky","year":"2006","unstructured":"Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, DiPaola RS, Abate-Shen C (2006) Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice. Clin Cancer Res 12:5895\u20135901","journal-title":"Clin Cancer Res"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ccell.2023.02.004","volume":"41","author":"N Bancaro","year":"2023","unstructured":"Bancaro N, Cal\u00ec B, Troiani M, Elia AR, Arzola RA, Attanasio G, Lai P, Crespo M, Gurel B, Pereira R et al (2023) Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer. Cancer Cell 41:602\u2013619.e11","journal-title":"Cancer Cell"},{"key":"417_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41574-019-0312-5","volume":"16","author":"D Bikle","year":"2020","unstructured":"Bikle D, Christakos S (2020) New aspects of vitamin D metabolism and action\u2014addressing the skin as source and target. Nat Rev Endocrinol 16:234\u2013252","journal-title":"Nat Rev Endocrinol"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"105484","DOI":"10.1016\/j.jsbmb.2019.105484","volume":"195","author":"CC Blajszczak","year":"2019","unstructured":"Blajszczak CC, Nonn L (2019) Vitamin D regulates prostate cell metabolism via genomic and non-genomic mitochondrial redox-dependent mechanisms. J Steroid Biochem Mol Biol 195:105484","journal-title":"J Steroid Biochem Mol Biol"},{"key":"417_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","volume":"559","author":"A Calcinotto","year":"2018","unstructured":"Calcinotto A, Spataro C, Zagato E, Di Mitri D, Gil V, Crespo M, De Bernardis G, Losa M, Mirenda M, Pasquini E et al (2018) IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature 559:363\u2013369","journal-title":"Nature"},{"key":"417_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115816","volume":"9","author":"M Consiglio","year":"2014","unstructured":"Consiglio M, Destefanis M, Morena D, Foglizzo V, Forneris M, Pescarmona G, Silvagno F (2014) The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation. PLoS ONE 9:e115816","journal-title":"PLoS ONE"},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, Van Den Bergh RCN, Briers E, Van Den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: Screening, diagnosis, and local treatment with curative intent. Eur Urol 86:148\u2013163","journal-title":"Eur Urol"},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.trecan.2024.06.005","volume":"10","author":"J Corres-Mendizabal","year":"2024","unstructured":"Corres-Mendizabal J, Zacchi F, Mart\u00edn-Mart\u00edn N, Mateo J, Carracedo A (2024) Metastatic hormone-na\u00efve prostate cancer: a distinct biological entity. Trends Cancer 10:825\u2013841","journal-title":"Trends Cancer"},{"key":"417_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.acuro.2022.02.002","volume":"46","author":"G De Velasco Oria De Rueda","year":"2022","unstructured":"De Velasco Oria De Rueda G, Plata Bello AC, Landeira M, Mateo M, Anguita P, Pranzo A, Snijder R, Garnham A, Hern\u00e1ndez I (2022) Incidence, prevalence, and treatment patterns in metastatic hormone-sensitive prostate cancer in Spain: ECHOS study. Actas Urol Esp 46:557\u2013564","journal-title":"Actas Urol Esp"},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"101546","DOI":"10.1016\/j.smim.2021.101546","volume":"57","author":"DEM Duits","year":"2021","unstructured":"Duits DEM, De Visser KE (2021) Impact of cancer cell-intrinsic features on neutrophil behavior. Semin Immunol 57:101546","journal-title":"Semin Immunol"},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3691","volume":"14","author":"D Feldman","year":"2014","unstructured":"Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14:342\u2013357","journal-title":"Nat Rev Cancer"},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1158\/1940-6207.CAPR-18-0401","volume":"12","author":"JC Fleet","year":"2019","unstructured":"Fleet JC, Kovalenko PL, Li Y, Smolinski J, Spees C, Yu J-G, Thomas-Ahner JM, Cui M, Neme A, Carlberg C et al (2019) Vitamin D signaling suppresses early prostate carcinogenesis in TgAPT121 mice. Cancer Prev Res 12:343\u2013356","journal-title":"Cancer Prev Res"},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/pros.22742","volume":"74","author":"G Gandaglia","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, Trudeau V, Shariat SF, Kim SP, Perrotte P, Montorsi F, Briganti A, Trinh Q et al (2014) Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate 74:210\u2013216","journal-title":"Prostate"},{"key":"417_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51450-2","volume":"15","author":"MK Graham","year":"2024","unstructured":"Graham MK, Wang R, Chikarmane R, Abel B, Vaghasia A, Gupta A, Zheng Q, Hicks J, Sysa-Shah P, Pan X et al (2024) Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Nat Commun 15:7414","journal-title":"Nat Commun"},{"key":"417_CR20","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","volume":"41","author":"JE Hawley","year":"2023","unstructured":"Hawley JE, Obradovic AZ, Dallos MC, Lim EA, Runcie K, Ager CR, McKiernan J, Anderson CB, Decastro GJ, Weintraub J et al (2023) Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell 41:1972\u20131988.e5","journal-title":"Cancer Cell"},{"key":"417_CR21","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/cncr.31384","volume":"124","author":"JT Helgstrand","year":"2018","unstructured":"Helgstrand JT, R\u00f8der MA, Klemann N, Toft BG, Lichtensztajn DY, Brooks JD, Brasso K, Vainer B, Iversen P (2018) Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer\u2014a population-based analysis of 2 national cohorts. Cancer 124:2931\u20132938","journal-title":"Cancer"},{"key":"417_CR22","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1200\/JCO.2010.30.9880","volume":"29","author":"WK Hendrickson","year":"2011","unstructured":"Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW et al (2011) Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. JCO 29:2378\u20132385","journal-title":"JCO"},{"key":"417_CR23","doi-asserted-by":"publisher","first-page":"106497","DOI":"10.1016\/j.jsbmb.2024.106497","volume":"240","author":"D Kermpatsou","year":"2024","unstructured":"Kermpatsou D, Olsson F, W\u00e5hl\u00e9n E, S\u00f6derberg O, Lennartsson J, Norlin M (2024) Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): Effects on proliferation, migration, and genes in control of active vitamin D. J Steroid Biochem Mol Biol 240:106497","journal-title":"J Steroid Biochem Mol Biol"},{"key":"417_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L, Kumar B, Koul S, Maroni P, Koul HK (2009) Oxidative stress in prostate cancer. Cancer Lett 282:125\u2013136","journal-title":"Cancer Lett"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"C-L Kuo","year":"2022","unstructured":"Kuo C-L, Ponneri Babuharisankar A, Lin Y-C, Lien H-W, Lo YK, Chou H-Y, Tangeda V, Cheng L-C, Cheng AN, Lee AY-L (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?. J Biomed Sci 29:74","journal-title":"J Biomed Sci"},{"key":"417_CR26","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1111\/bph.16492","volume":"181","author":"K Len-Tayon","year":"2024","unstructured":"Len-Tayon K, Beraud C, Fauveau C, Belorusova AY, Chebaro Y, Mouri\u00f1o A, Massfelder T, Chauchereau A, Metzger D, Rochel N et al (2024) A vitamin D-based strategy overcomes chemoresistance in prostate cancer. Br J Pharmacol 181:4279\u20134293","journal-title":"Br J Pharmacol"},{"key":"417_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01522-8","volume":"24","author":"M Liaqat","year":"2024","unstructured":"Liaqat M, Khan RA, Fischer F, Kamal S (2024) Relationship between prostate-specific antigen, alkaline phosphatase levels, and time-to-tumor shrinkage: understanding the progression of prostate cancer in a longitudinal study. BMC Urol 24:137","journal-title":"BMC Urol"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s43018-021-00227-3","volume":"2","author":"ZA Lopez-Bujanda","year":"2021","unstructured":"Lopez-Bujanda ZA, Haffner MC, Chaimowitz MG, Chowdhury N, Venturini NJ, Patel RA, Obradovic A, Hansen CS, Jack\u00f3w J, Maynard JP et al (2021) Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nat Cancer 2:803\u2013818","journal-title":"Nat Cancer"},{"key":"417_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15: 550","journal-title":"Genome Biol"},{"key":"417_CR30","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","volume":"209","author":"W Lowrance","year":"2023","unstructured":"Lowrance W, Dreicer R, Jarrard DF, Scarpato KR, Kim SK, Kirkby E, Buckley DI, Griffin JC, Cookson MS (2023) Updates to advanced prostate cancer: AUA\/SUO Guideline (2023). J Urol 209:1082\u20131090","journal-title":"J Urol"},{"key":"417_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nature21676","volume":"543","author":"X Lu","year":"2017","unstructured":"Lu X, Horner JW, Paul E, Shang X, Troncoso P, Deng P, Jiang S, Chang Q, Spring DJ, Sharma P et al (2017) Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature 543:728\u2013732","journal-title":"Nature"},{"key":"417_CR32","doi-asserted-by":"publisher","first-page":"105522","DOI":"10.1016\/j.jsbmb.2019.105522","volume":"198","author":"JE Manson","year":"2020","unstructured":"Manson JE, Bassuk SS, Buring JE (2020) Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol 198:105522","journal-title":"J Steroid Biochem Mol Biol"},{"key":"417_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.3029866","volume":"235","author":"DP McDonnell","year":"1987","unstructured":"McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O\u2019Malley BW (1987) Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235:1214\u20131217","journal-title":"Science"},{"key":"417_CR34","doi-asserted-by":"publisher","first-page":"vi257","DOI":"10.1093\/annonc\/mdw372.41","volume":"27","author":"N Mehra","year":"2016","unstructured":"Mehra N, Seed G, Lambros M, Sharp A, Fontes MS, Crespo M, Sumanasuriya S, Yuan W, Boysen G, Riisnaes R et al (2016) Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS). Ann Oncol 27:vi257","journal-title":"Ann Oncol"},{"key":"417_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00401-017-1731-9","volume":"134","author":"A Meyer","year":"2017","unstructured":"Meyer A, Laverny G, Allenbach Y, Grelet E, Ueberschlag V, Echaniz-Laguna A, Lannes B, Alsaleh G, Charles AL, Singh F et al (2017) IFN-\u03b2-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis. Acta Neuropathol 134:655\u2013666","journal-title":"Acta Neuropathol"},{"key":"417_CR36","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1158\/1078-0432.CCR-13-3085","volume":"20","author":"AB Murphy","year":"2014","unstructured":"Murphy AB, Nyame Y, Martin IK, Catalona WJ, Hollowell CMP, Nadler RB, Kozlowski JM, Perry KT, Kajdacsy-Balla A, Kittles R (2014) Vitamin D deficiency predicts prostate biopsy outcomes. Clin Cancer Res 20:2289\u20132299","journal-title":"Clin Cancer Res"},{"key":"417_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","volume":"4","author":"MP Murphy","year":"2022","unstructured":"Murphy MP, Bayir H, Belousov V, Chang CJ, Davies KJA, Davies MJ, Dick TP, Finkel T, Forman HJ, Janssen-Heininger Y et al (2022) Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metab 4:651\u2013662","journal-title":"Nat Metab"},{"key":"417_CR38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41585-024-00875-x","volume":"21","author":"X Ni","year":"2024","unstructured":"Ni X, Wei Y, Li X, Pan J, Fang B, Zhang T, Lu Y, Ye D, Zhu Y (2024) From biology to the clinic\u2014exploring liver metastasis in prostate cancer. Nat Rev Urol 21:593\u2013614","journal-title":"Nat Rev Urol"},{"key":"417_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.prnil.2016.05.002","volume":"4","author":"B Oh","year":"2016","unstructured":"Oh B, Figtree G, Costa D, Eade T, Hruby G, Lim S, Elfiky A, Martine N, Rosenthal D, Clarke S et al (2016) Oxidative stress in prostate cancer patients: a systematic review of case control studies. Prostate Int 4:71\u201387","journal-title":"Prostate Int"},{"key":"417_CR40","first-page":"302","volume":"9","author":"S Ohtake","year":"2018","unstructured":"Ohtake S, Kawahara T, Ishiguro Y, Takeshima T, Kuroda S, Izumi K, Miyamoto H, Uemura H (2018) Oxidative stress marker 8-hydroxyguanosine is more highly expressed in prostate cancer than in benign prostatic hyperplasia. Mol Clin Onc 9:302\u2013304","journal-title":"Mol Clin Onc"},{"key":"417_CR41","doi-asserted-by":"publisher","first-page":"1133160","DOI":"10.3389\/fimmu.2023.1133160","volume":"14","author":"J Pan","year":"2023","unstructured":"Pan J, Ma Z, Liu B, Qian H, Shao X, Liu J, Wang Q, Xue W (2023) Identification of cancer-associated fibroblasts subtypes in prostate cancer. Front Immunol 14:1133160","journal-title":"Front Immunol"},{"key":"417_CR42","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1084\/jem.20171207","volume":"215","author":"M Parisotto","year":"2018","unstructured":"Parisotto M, Grelet E, El Bizri R, Dai Y, Terzic J, Eckert D, Gargowitsch L, Bornert J-M, Metzger D (2018) PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. J Exp Med 215:1749\u20131763","journal-title":"J Exp Med"},{"key":"417_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2562220","volume":"14","author":"D Pervizou","year":"2025","unstructured":"Pervizou D, De Chiara J, Spinelli L, Nestor-Martin M, Chasson L, Len-Tayon K, Yanushko D, Fiore F, Baj\u00e9noff M, Malissen B et al (2025) Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression. Oncoimmunology 14:2562220","journal-title":"Oncoimmunology"},{"key":"417_CR44","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1073\/pnas.76.11.5485","volume":"76","author":"JW Pike","year":"1979","unstructured":"Pike JW, Haussler MR (1979) Purification of chicken intestinal receptor for 1,25-dihydroxyvitamin D. Proc Natl Acad Sci USA 76:5485\u20135489","journal-title":"Proc Natl Acad Sci USA"},{"key":"417_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2024.102710","volume":"34","author":"G Ploussard","year":"2024","unstructured":"Ploussard G, Dariane C, Mathieu R, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Rozet F et al (2024) French AFU cancer committee guidelines\u2014update 2024\u20132026: Prostate cancer\u2014management of metastatic disease and castration resistance. Fr J Urol 34:102710","journal-title":"Fr J Urol"},{"key":"417_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1464-410X.2006.06663.x","volume":"99","author":"D Pouessel","year":"2007","unstructured":"Pouessel D, Gallet B, Bibeau F, Avanc\u00e8s C, Iborra F, S\u00e9nesse P, Culine S (2007) Liver metastases in prostate carcinoma: clinical characteristics and outcome. BJU Int 99:807\u2013811","journal-title":"BJU Int"},{"key":"417_CR47","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1073\/pnas.0712021105","volume":"105","author":"CK Ratnacaram","year":"2008","unstructured":"Ratnacaram CK, Teletin M, Jiang M, Meng X, Chambon P, Metzger D (2008) Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma. Proc Natl Acad Sci USA 105:2521\u20132526","journal-title":"Proc Natl Acad Sci USA"},{"key":"417_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van Der Kwast T, Bristow RG (2021) Prostate cancer. Nat Rev Dis Prim 7:9","journal-title":"Nat Rev Dis Prim"},{"key":"417_CR49","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/ijms19061672","volume":"19","author":"C Ricca","year":"2018","unstructured":"Ricca C, Aillon A, Bergandi L, Alotto D, Castagnoli C, Silvagno F (2018) Vitamin D receptor is necessary for mitochondrial function and cell health. IJMS 19:1672","journal-title":"IJMS"},{"key":"417_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1097-2765(00)80413-X","volume":"5","author":"N Rochel","year":"2000","unstructured":"Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D (2000) The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5:173\u2013179","journal-title":"Mol Cell"},{"key":"417_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/path.4924","volume":"243","author":"L Sackmann Sala","year":"2017","unstructured":"Sackmann Sala L, Boutillon F, Menara G, De Goyon-P\u00e9lard A, Lepr\u00e9vost M, Codzamanian J, Lister N, Pencik J, Clark A, Cagnard N et al (2017) A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours. J Pathol 243:51\u201364","journal-title":"J Pathol"},{"key":"417_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","volume":"22","author":"EM Schaeffer","year":"2024","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, Cheng HH, D\u2019Amico AV, Desai N, Dorff T et al (2024) Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines. J Natl Compr Cancer Netw 22:140\u2013150","journal-title":"J Natl Compr Cancer Netw"},{"key":"417_CR53","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"417_CR54","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA A Cancer J Clin 75:10\u201345","journal-title":"CA A Cancer J Clin"},{"key":"417_CR55","doi-asserted-by":"publisher","first-page":"R294","DOI":"10.1530\/EC-18-0283","volume":"7","author":"Z Song","year":"2018","unstructured":"Song Z, Yao Q, Zhuo Z, Ma Z, Chen G (2018) Circulating vitamin D level and mortality in prostate cancer patients: a dose\u2013response meta-analysis. Endocr Connect 7:R294\u2013R303","journal-title":"Endocr Connect"},{"key":"417_CR56","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R (2019) Comprehensive integration of single-cell data. Cell 177:1888\u20131902.e21","journal-title":"Cell"},{"key":"417_CR57","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","volume":"24","author":"J Stultz","year":"2021","unstructured":"Stultz J, Fong L (2021) How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer. Prostate Cancer Prostatic Dis 24:697\u2013717","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"417_CR58","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 71:209\u2013249","journal-title":"CA A Cancer J Clin"},{"key":"417_CR59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature08361","volume":"461","author":"X Wang","year":"2009","unstructured":"Wang X, Julio MK, Economides KD, Walker D, Yu H, Halili MV, Hu Y-P, Price SM, Abate-Shen C, Shen MM (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461:495\u2013500","journal-title":"Nature"},{"key":"417_CR60","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.freeradbiomed.2022.11.013","volume":"193","author":"P Xu","year":"2022","unstructured":"Xu P, Lin B, Deng X, Huang K, Zhang Y, Wang N (2022) VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2\/GPX4 pathway in age-related osteoporosis. Free Radic Biol Med 193:720\u2013735","journal-title":"Free Radic Biol Med"},{"key":"417_CR61","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/en.2012-1542","volume":"154","author":"Y Yamamoto","year":"2013","unstructured":"Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, Sato T, Kawano H, Aihara K, Nakamichi Y et al (2013) Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 154:1008\u20131020","journal-title":"Endocrinology"},{"key":"417_CR62","doi-asserted-by":"publisher","first-page":"e13095","DOI":"10.1111\/acel.13095","volume":"19","author":"R Yang","year":"2020","unstructured":"Yang R, Chen J, Zhang J, Qin R, Wang R, Qiu Y, Mao Z, Goltzman D, Miao D (2020) 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis. Aging Cell 19:e13095","journal-title":"Aging Cell"},{"key":"417_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pros.24068","volume":"81","author":"Y Yang","year":"2021","unstructured":"Yang Y, Attwood K, Bshara W, Mohler JL, Guru K, Xu B, Kalinski P, Chatta G (2021) High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy. Prostate 81:20\u201328","journal-title":"Prostate"},{"key":"417_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07361-1","volume":"16","author":"D Yanushko","year":"2025","unstructured":"Yanushko D, German Falcon B, El Bizri R, Pervizou D, Dolgos R, Keime C, Ye T, Thibault-Carpentier C, Le Magnen C, Henri S et al (2025) p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment. Cell Death Dis 16:46","journal-title":"Cell Death Dis"},{"key":"417_CR65","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/oncolo\/oyad102","volume":"28","author":"E Yeked\u00fcz","year":"2023","unstructured":"Yeked\u00fcz E, McKay RR, Gillessen S, Choueiri TK, \u00dcr\u00fcn Y (2023) Visceral metastasis predicts response to new hormonal agents in metastatic castration-sensitive prostate cancer. Oncologist 28:596\u2013603","journal-title":"Oncologist"},{"key":"417_CR66","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang L-G, Yan G-R, He Q-Y (2015) DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics 31:608\u2013609","journal-title":"Bioinformatics"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00417-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00417-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00417-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:44:38Z","timestamp":1779065078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00417-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,15]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00417-5","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}